[go: up one dir, main page]

BRPI0815673A2 - Sulfonas cíclicas substituídas por aminobenzila úteis como inibidores de bace. - Google Patents

Sulfonas cíclicas substituídas por aminobenzila úteis como inibidores de bace.

Info

Publication number
BRPI0815673A2
BRPI0815673A2 BRPI0815673-5A2A BRPI0815673A BRPI0815673A2 BR PI0815673 A2 BRPI0815673 A2 BR PI0815673A2 BR PI0815673 A BRPI0815673 A BR PI0815673A BR PI0815673 A2 BRPI0815673 A2 BR PI0815673A2
Authority
BR
Brazil
Prior art keywords
aminobenzile
sulphones
cycle
replaced
useful
Prior art date
Application number
BRPI0815673-5A2A
Other languages
English (en)
Inventor
Emmanuelle Briard
Rainer Martin Lueoend
Rainer Machauer
Henrik Moebitz
Olivier Rogel
Jean-Michel Rondeau
Heinrich Rueeger
Marina Tintelnot-Blomley
Siem Jacob Veenstra
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0815673A2 publication Critical patent/BRPI0815673A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0815673-5A2A 2007-08-23 2008-08-22 Sulfonas cíclicas substituídas por aminobenzila úteis como inibidores de bace. BRPI0815673A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07114881 2007-08-23
EP08160123 2008-07-10
PCT/EP2008/061030 WO2009024615A1 (en) 2007-08-23 2008-08-22 Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors

Publications (1)

Publication Number Publication Date
BRPI0815673A2 true BRPI0815673A2 (pt) 2015-02-18

Family

ID=39789883

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815673-5A2A BRPI0815673A2 (pt) 2007-08-23 2008-08-22 Sulfonas cíclicas substituídas por aminobenzila úteis como inibidores de bace.

Country Status (15)

Country Link
US (1) US20090054427A1 (pt)
EP (1) EP2190833A1 (pt)
JP (1) JP2010536831A (pt)
KR (1) KR20100061805A (pt)
CN (1) CN101835771A (pt)
AR (1) AR068062A1 (pt)
AU (1) AU2008290561A1 (pt)
BR (1) BRPI0815673A2 (pt)
CA (1) CA2697254A1 (pt)
CL (1) CL2008002480A1 (pt)
EA (1) EA201000340A1 (pt)
MX (1) MX2010002007A (pt)
PE (1) PE20090953A1 (pt)
TW (1) TW200916097A (pt)
WO (1) WO2009024615A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011527311A (ja) * 2008-07-10 2011-10-27 ノバルティス アーゲー Bace阻害薬として有用なアミノベンジル置換環状スルホン誘導体
US9066948B2 (en) 2010-07-16 2015-06-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Oxadiazolo[3,2-a]pyrimidines and thiadiazolo[3,2-a]pyrimidines
US9242943B2 (en) * 2011-01-18 2016-01-26 Siena Biotech S.P.A. 1,4 oxazines as BACE1 and/or BACE2 inhibitors
EP2804610B1 (en) 2012-01-16 2018-10-31 The Rockefeller University Organic compounds
US10202355B2 (en) 2013-02-12 2019-02-12 Buck Institute For Research On Aging Hydantoins that modulate bace-mediated app processing
CN106674264A (zh) * 2016-12-20 2017-05-17 苏州汉德创宏生化科技有限公司 (2,2,2‑三氟乙氧基)苯硼酸类化合物的合成方法
EP3810134A4 (en) 2018-06-19 2022-03-30 Celecor Therapeutics, Inc. DEUTERED RUC-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888325B1 (en) * 1996-02-07 2002-05-29 Warner-Lambert Company Novel cyclic amino acids as pharmaceutical agents
AU759392B2 (en) * 1997-12-16 2003-04-10 Warner-Lambert Company 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
GB0602951D0 (en) * 2006-02-14 2006-03-29 Novartis Ag Organic Compounds

Also Published As

Publication number Publication date
US20090054427A1 (en) 2009-02-26
EA201000340A1 (ru) 2010-08-30
AU2008290561A1 (en) 2009-02-26
WO2009024615A1 (en) 2009-02-26
CN101835771A (zh) 2010-09-15
KR20100061805A (ko) 2010-06-09
CA2697254A1 (en) 2009-02-26
AR068062A1 (es) 2009-11-04
CL2008002480A1 (es) 2009-05-15
PE20090953A1 (es) 2009-08-10
JP2010536831A (ja) 2010-12-02
EP2190833A1 (en) 2010-06-02
TW200916097A (en) 2009-04-16
MX2010002007A (es) 2010-03-10

Similar Documents

Publication Publication Date Title
NO2021006I1 (no) Quofenix, delafloksacin
BRPI1009415A2 (pt) escova de dentes.
BRPI1010301A2 (pt) composição.
BRPI1008939A2 (pt) 2-mercaptoquinolina-3-carboxamidas substituídas como moduladores de kncq2/3.
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
BRPI0906625A2 (pt) Derivados de tio-2-amino-quinolina-6-substituída úteis como inibidores da beta-secretase (bace)
UY3955Q (es) Carrocería
BRPI1007047A2 (pt) Biorrefino irganosolv de cana-de-açúcar inteira.
BRPI0811044A2 (pt) 2-morfolin-4-il-pirimidinas como inibidores de p13k.
BRPI0806537A2 (pt) Indazóis substituídos por 5-piridinona
BRPI1005525A2 (pt) compostos de azaazuleno
BRPI0907925A2 (pt) Ativadores de glicoquinase.
BRPI0915524A2 (pt) conjunto de aerofólio
EP2344471A4 (en) 7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI0912013A2 (pt) mecanismo de disposição de aerofólio
BRPI0919898A2 (pt) 4,5,6,7-tetra-hidrotienopiridinas substituídas como moduladores de kcnq2/3
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
BRPI0806506A2 (pt) Indazóis substituídos por 5-furopiridinona
BRPI0906714A2 (pt) Derivados de oxazepinopirimidona heteroarilamida substituídos.
BRPI1013157A2 (pt) meio de fixação.
BRPI1016192A2 (pt) derivados de soxazol.
EP2459573A4 (en) SUBSTITUTED 1,2-AZABORIN HETEROCYCLES
FR2947857B1 (fr) Agencement de deshuileur
ES1070267Y (es) Deposito de heces equino

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]